HDAC4 has previously been shown to induce cell proliferation in glioma, osteosarcoma, gastric-, esophageal-, and colon cancer, while it had only modest effects in urothelial carcinoma cell lines and multiple myeloma [5,8,9,13,28,29,30]. Here, HDAC4 is linked to central nervous system cancer.